Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey

BACKGROUND: Despite their limited licensed indications, anti–interleukin-1 (anti–IL-1) agents are often used in clinical practice for an increasing number of auto-inflammatory diseases. We conducted a national cross-sectional observational study from January 2011 to January 2013 to record the off-la...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi-Semerano, Linda, Fautrel, Bruno, Wendling, Daniel, Hachulla, Eric, Galeotti, Caroline, Semerano, Luca, Touitou, Isabelle, Koné-Paut, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340831/
https://www.ncbi.nlm.nih.gov/pubmed/25758134
http://dx.doi.org/10.1186/s13023-015-0228-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340831/
https://www.ncbi.nlm.nih.gov/pubmed/25758134
http://dx.doi.org/10.1186/s13023-015-0228-7

Ejemplares similares